Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion type Assertion NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_head.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion description "[We examined the associations of CTLA4 single-nucleotide polymorphisms (SNPs) at promoter site -318 and exon-1 site 49 with clearance of hepatitis C virus (HCV) after treatment with combination interferon-alpha plus ribavirin (IFN-alpha+R) therapy in 79 white sustained responders (SRs) and 79 nonresponders (NRs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_provenance.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion evidence source_evidence_literature NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_provenance.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion SIO_000772 12696006 NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_provenance.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion wasDerivedFrom gad-20130706 NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_provenance.
- NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_assertion wasGeneratedBy ECO_0000203 NP46501.RA6wzRwbzYt55g2HJP32OM591np4bZVhPD2rj7lEOQebw130_provenance.